SG Americas Securities LLC Takes Position in Axcelis Technologies, Inc. $ACLS

SG Americas Securities LLC bought a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 14,166 shares of the semiconductor company’s stock, valued at approximately $1,138,000.

Other large investors have also recently modified their holdings of the company. Allspring Global Investments Holdings LLC increased its position in shares of Axcelis Technologies by 1,344.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock valued at $10,388,000 after purchasing an additional 102,040 shares during the last quarter. Summit Global Investments bought a new position in Axcelis Technologies in the 3rd quarter valued at $789,000. Squarepoint Ops LLC grew its position in Axcelis Technologies by 37.0% in the 2nd quarter. Squarepoint Ops LLC now owns 100,023 shares of the semiconductor company’s stock valued at $6,971,000 after acquiring an additional 27,021 shares during the last quarter. AlphaQuest LLC bought a new position in Axcelis Technologies in the 3rd quarter valued at $1,347,000. Finally, Jackson Creek Investment Advisors LLC bought a new position in Axcelis Technologies in the 3rd quarter valued at $2,177,000. Institutional investors own 89.98% of the company’s stock.

Insiders Place Their Bets

In other news, Director Jorge Titinger sold 1,000 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $80.00, for a total transaction of $80,000.00. Following the transaction, the director owned 6,477 shares of the company’s stock, valued at approximately $518,160. This represents a 13.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Russell Low sold 1,244 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $94.06, for a total value of $117,010.64. Following the transaction, the chief executive officer directly owned 132,282 shares in the company, valued at $12,442,444.92. The trade was a 0.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.48% of the stock is currently owned by corporate insiders.

Axcelis Technologies Price Performance

ACLS opened at $104.65 on Thursday. Axcelis Technologies, Inc. has a 12-month low of $41.38 and a 12-month high of $105.15. The company has a current ratio of 4.77, a quick ratio of 3.11 and a debt-to-equity ratio of 0.04. The business’s fifty day simple moving average is $88.43 and its 200-day simple moving average is $87.15. The company has a market capitalization of $3.22 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 11.37 and a beta of 1.65.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.37. Axcelis Technologies had a return on equity of 13.73% and a net margin of 14.33%.The business had revenue of $238.33 million for the quarter, compared to the consensus estimate of $215.04 million. During the same quarter in the prior year, the company earned $1.54 EPS. The business’s revenue was down 5.6% compared to the same quarter last year. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. On average, equities research analysts anticipate that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on ACLS. Bank of America upped their price objective on Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a research report on Tuesday, January 13th. Zacks Research downgraded Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research report on Friday, February 20th. B. Riley Financial cut their price objective on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research report on Monday, December 22nd. Finally, Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $101.50.

Axcelis Technologies Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.